Viyash Scientific (512529) Q4 98/99 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 98/99 earnings summary
29 Oct, 2026Executive summary
FY ended Mar. 31, 1999: profit before tax was ₹1.827m and profit after tax ₹1.653m, versus ₹53,147 and ₹36,882, respectively, in FY98.
Earnings were driven mainly by investment-sale profit and dividend income; the board retained earnings for future operations and recommended no dividend.
Financial highlights
Miscellaneous income was ₹1.870m versus ₹89,475 YoY; administrative and other expenses were ₹43,025 versus ₹36,327.
Other income included ₹1.590m profit on sale of investments, ₹171,608 dividend income, ₹101,382 Badla trading income and ₹7,693 interest.
Profit carried to the balance sheet rose to ₹2.044m from ₹390,182; reserves and surplus were ₹2.044m at Mar. 31, 1999.
Outlook and guidance
Earnings were retained to support future operations; no equity dividend was recommended.
Y2K contingency plans were in place for any hardware or software found non-compliant; estimated compliance costs were not expected to be significant.
Latest events from Viyash Scientific
- FY1997-98 profit was Rs 36,882; earnings were retained and Rs 10 crore borrowing authority proposed.512529
Q4 97/98 - FY02 loss narrowed, but Rs 55.57m in advances remained subject to confirmation.512529
Q4 01/02 - FY03 loss widened as Rs 54.50m in loans and advances dominated the balance sheet.512529
Q4 02/03 - ₹295.51 lakh FY04 net profit; growth guidance exceeded 50% post-amalgamation.512529
Q4 03/04 - FY05 profit rose as capacity expansion and new markets became central priorities.512529
Q4 04/05 - FY06 growth and new capacity supported expansion, while rising input costs remained a key risk.512529
Q4 05/06 - Sales climbed 23%; adjusted PAT rose 32% as R&D and veterinary APIs set the growth agenda.512529
Q4 06/07 - Transchem expanded the business as currency pressure and higher costs squeezed profit.512529
Q4 07/08 - Standalone profit grew, but consolidation swung to a ₹1,466 lakh net loss.512529
Q4 08/09